Immediate Impact
42 hit
Citing Papers
Liver diseases: epidemiology, causes, trends and predictions
2025 Hit
Primary sclerosing cholangitis
2025 Hit
Works of Richard Pencek being referenced
INTEGRIS-PSC phase 2a study: evaluating the safety, tolerability, and pharmacokinetics of bexotegrast (PLN-74809) in participants with primary sclerosing cholangitis
2023
A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
2020